Michael Friedrich (doctor)

from Wikipedia, the free encyclopedia

Michael Friedrich (* 1966 in Wadern ) is a German gynecologist , professor and director of the Clinic for Gynecology and Obstetrics at the Helios Clinic in Krefeld . His clinical and research focus is on the surgical and drug treatment of all gynecological malignancies, including breast cancer .

Life

Friedrich studied human medicine from 1985 to 1991 at the Medical Faculty of the Albert Ludwig University of Freiburg . Since 1988 he has been a member of the Catholic student association KDStV Hercynia Freiburg im Breisgau . Following his studies, he completed his specialist training as a gynecologist until 1997. In 1999 he was appointed senior physician at the University Women's Clinic in Homburg / Saar. He received his license to practice medicine in 1992. In 2003 and 2004, Friedrich worked on scientific observations at the Memorial Sloan-Kettering Cancer Center , New York, at the Northern Gynecologic Oncology Center, Queen Elizabeth Hospital, Gateshead , Great Britain and at the Istituto Nazionale per lo Studio e la Cura die Tumori, Milan and European Institute of Oncology. In 2003 he became senior physician in charge and in 2004 deputy clinic director of the University Women's Clinic at the University Medical Center Schleswig-Holstein , Lübeck campus. In 2005 Friedrich completed a correspondence course in business administration for doctors at the Cologne University of Applied Sciences. In 2007, the Helios Klinikum Krefeld appointed Friedrich as Director of the Clinic for Gynecology and Obstetrics with a Breast Center, Gynecological Cancer Center, Continence Center, Endometriosis Center and Perinatal Center Level I as well as the Center for Prenatal Medicine. Since 2009 he has headed the Gynecology and Obstetrics specialist group at Helios Kliniken . In 2000 he became a member of the Mamma organ committee of the Gynecological Oncology Working Group and played a key role in the development of guidelines for the treatment of breast cancer. Since 2010 he has been a member of the ethics committee of the Medical Association of North Rhine-Westphalia and since 2012 a member of the board of the Federal Association of Leading Doctors in Gynecology and Obstetrics (BLFG). In 2016 he was appointed to the internationally renowned Society of Pelvic Surgeons due to his expertise in the surgical treatment of gynecological malignancies. Friedrich completed his habilitation in 2000 on the subject of vitamin D metabolism in gynecological oncology at the University Women's Clinic Homburg / Saar and in 2005 was appointed adjunct professor for gynecology at the Medical Faculty of the University of Lübeck .

Contributions to science and research

Friedrich undertook experimental investigations into the metabolism of vitamin D and prostaglandin in gynecological oncology. He was the first to demonstrate the vitamin D receptor in vulvar cancer and its precursors, which had clinical implications. He also focused on the role of the DNA mismatch repair system in the pathogenesis of breast cancer and in the development of chemotherapy-induced resistance. This was followed by prospective studies to evaluate BoneTRAP as a serum marker for bone resorption and to monitor oral Bonefos therapy in osseous metastatic breast cancer and post-aggression metabolism after various gynecological surgical procedures. He devoted a special focus of his research to ovarian cancer. So Friedrich evaluated the effectiveness of new chemotherapy agents in the treatment of human ovarian cancer - xenografts . and the benefits of hyperthermic intraperitoneal chemotherapy in ovarian cancer .

Membership in scientific associations and editorial boards

Friedrich is a member of u. a. following scientific associations: European Society of Gynecologic Oncology (ESGO), International Gynecologic Cancer Society (IGCS), European Society for Medical Oncology (ESMO), American Society of Oncology (ASCO), European Society of Mastology Oncology (EUSOMA), Gynecological Oncology Working Group (AGO) of the German Cancer Society, Society of Pelvic Surgeons Friedrich is also a member of the board of the Federal Working Group of Leading Doctors in Gynecology and Obstetrics (BLFG)

Friedrich was or is a member of the editorial board or the advisory board of International Journal Clinical and Experimental Obstetrics and Gynecology (1999), European Journal of Gynaecological Oncology (2004), Scientific Advisory Board of the International Institute of Anticancer Research (2004), International Journal IN VIVO (2007), ISRN Obstetrics and Gynecology (2010). Friedrich is also active as a reviewer for scientific journals, including the European Journal of Gynecological Oncology, European Journal of Cancer and the European Journal of Gynecology, Ostetrics and Reproductive Biology.

honors and awards

  • Science Award of the Middle Rhine Society for Gynecology and Obstetrics (1999)
  • Science Award of the North German Society for Gynecology and Obstetrics (2003)
  • Society for applied meta-research: "Distinguished as one of the leading researchers in medicine due to the attention it receives in the science community" (2003)

Publications

Web links

Individual evidence

  1. ↑ Board of BLFG
  2. ↑ Michael Friedrich CV
  3. ↑ Thill M, Fischer D, Becker S, Cordes T, Dittmer C, Diedrich K, Salehin D, Friedrich M. Prostaglandin metabolizing enzymes in correlation with vitamin D receptor in benign and malignant breast cell lines. Anticancer Res. 2009; Sep; 29 (9): 3619-25
  4. ↑ Salehin D, Haugk C, Thill M, Cordes T, William M, Hemmerlein B, Friedrich M. Vitamin D receptor expression in patients with vulvar cancer. Anticancer Res. 2012 Jan; 32 (1): 283-9.
  5. ↑ NATUM: New hopes for patients with advanced ovarian cancer (HIPEC)
  6. ↑ Working Group Gynecological Oncology .
  7. ^ Forum for Women's Health: Admission of M. Friedrich to the Society of Pelvic Surgeons
  8. ↑ BLFG Board of Directors
personal data
SURNAME Friedrich, Michael
BRIEF DESCRIPTION German gynecologist
DATE OF BIRTH 1966
PLACE OF BIRTH Waders